0001628280-21-014218.txt : 20210721 0001628280-21-014218.hdr.sgml : 20210721 20210721205305 ACCESSION NUMBER: 0001628280-21-014218 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210721 FILED AS OF DATE: 20210721 DATE AS OF CHANGE: 20210721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Casdin Partners GP, LLC CENTRAL INDEX KEY: 0001534260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40646 FILM NUMBER: 211105745 BUSINESS ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS STREET 2: SUITE 1140 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212.300.5575 MAIL ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS STREET 2: SUITE 1140 CITY: NEW YORK STATE: NY ZIP: 10019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Casdin Capital, LLC CENTRAL INDEX KEY: 0001534261 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40646 FILM NUMBER: 211105746 BUSINESS ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS STREET 2: SUITE 2600 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212.300.5575 MAIL ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS STREET 2: SUITE 2600 CITY: NEW YORK STATE: NY ZIP: 10019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC CENTRAL INDEX KEY: 0001864554 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40646 FILM NUMBER: 211105743 BUSINESS ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS STREET 2: SUITE 2600 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-897-5430 MAIL ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS STREET 2: SUITE 2600 CITY: NEW YORK STATE: NY ZIP: 10019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Casdin Partners Master Fund, L.P. CENTRAL INDEX KEY: 0001534265 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40646 FILM NUMBER: 211105747 BUSINESS ADDRESS: STREET 1: WALKER HOUSE STREET 2: 87 MARY STREET CITY: GEORGE TOWN STATE: E9 ZIP: KY1-9001 BUSINESS PHONE: 212.300.5575 MAIL ADDRESS: STREET 1: WALKER HOUSE STREET 2: 87 MARY STREET CITY: GEORGE TOWN STATE: E9 ZIP: KY1-9001 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Casdin Private Growth Equity Fund, L.P. CENTRAL INDEX KEY: 0001823061 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40646 FILM NUMBER: 211105744 BUSINESS ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS STREET 2: SUITE 2600 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-897-5430 MAIL ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS STREET 2: SUITE 2600 CITY: NEW YORK STATE: NY ZIP: 10019 FORMER NAME: FORMER CONFORMED NAME: CASDIN PRIVATE GROWTH EQUITY FUND, L.P. DATE OF NAME CHANGE: 20200831 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Absci Corp CENTRAL INDEX KEY: 0001672688 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 453931977 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18105 SE MILL PLAIN BLVD CITY: VANCOUVER STATE: WA ZIP: 98683 BUSINESS PHONE: (360) 949-1041 MAIL ADDRESS: STREET 1: 18105 SE MILL PLAIN BLVD CITY: VANCOUVER STATE: WA ZIP: 98683 FORMER COMPANY: FORMER CONFORMED NAME: AbSci Corp DATE OF NAME CHANGE: 20201026 FORMER COMPANY: FORMER CONFORMED NAME: AbSci, Inc. DATE OF NAME CHANGE: 20201026 FORMER COMPANY: FORMER CONFORMED NAME: AbSci, LLC DATE OF NAME CHANGE: 20160420 3 1 wf-form3_162691516805201.xml FORM 3 X0206 3 2021-07-21 0 0001672688 Absci Corp ABSI 0001534265 Casdin Partners Master Fund, L.P. 1350 AVENUE OF THE AMERICAS, SUITE 2600 NEW YORK NY 10019 1 0 1 0 0001534261 Casdin Capital, LLC 1350 AVENUE OF THE AMERICAS, SUITE 2600 NEW YORK NY 10019 1 0 1 0 0001534260 Casdin Partners GP, LLC 1350 AVENUE OF THE AMERICAS, SUITE 2600 NEW YORK NY 10019 1 0 1 0 0001823061 Casdin Private Growth Equity Fund, L.P. 1350 AVENUE OF THE AMERICAS, SUITE 2600 NEW YORK NY 10019 1 0 1 0 0001864554 CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC 1350 AVENUE OF THE AMERICAS, SUITE 2600 NEW YORK NY 10019 1 0 1 0 Series E Preferred Stock Common Stock 4209573.0 D Convertible Note 13.12 Common Stock 973260.0 D Convertible Note 13.12 Common Stock 973260.0 I By Casdin Private Growth Equity Fund, L.P. These shares of the Issuer's Series E Preferred Stock will automatically convert on a one-for-3.3031 basis into the number of shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), shown in Column 3 immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series E Preferred Stock has no expiration date. These shares are held by Casdin Partners Master Fund, L.P. Casdin Capital, LLC ("Casdin Capital") is the investment adviser to Casdin Partners Master Fund, L.P., and Casdin Partners GP, LLC ("Casdin Partners GP") is the general partner of Casdin Partners Master Fund, L.P. Eli Casdin is the managing member of Casdin Capital and Casdin Partners GP. Each of Casdin Capital, Casdin Partners GP and Eli Casdin disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein, if any. Eli Casdin is a director of the Issuer and, accordingly, files separate Section 16 reports. This convertible promissory note ("Convertible Note") has a maturity date of September 16, 2023. The principal and accrued interest under the Convertible Note will convert upon the closing of the IPO into shares of Common Stock at a conversion price equal to $13.12 per share without payment of additional consideration. These shares are held by Casdin Private Growth Equity Fund, L.P. Casdin Capital is the investment adviser to Casdin Private Growth Equity Fund, L.P. and Casdin Private Growth Equity Fund GP, LLC ("Casdin Private Growth GP") is the general partner of Casdin Private Growth Equity Fund, L.P. Eli Casdin is the managing member of Casdin Capital and Casdin Private Growth GP. Each of Casdin Capital, Casdin Private Growth GP and Eli Casdin disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein, if any. Eli Casdin is a director of the Issuer and, accordingly, files separate Section 16 reports. Eli Casdin has been deputized to represent the Reporting Persons on the board of directors of the Issuer. By virtue of Mr. Casdin's representation, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), each of the Reporting Persons may be deemed directors by deputization of the Issuer. Mr. Casdin files separate Section 16 reports disclosing securities of the Issuer that he may be deemed to beneficially own for Section 16 purposes. Casdin Partners Master Fund, L.P., By: Casdin Partners GP, LLC, Its: General Partner, By: /s/ Eli Casdin, Its: Managing Member 2021-07-21 Casdin Capital, LLC, By: /s/ Eli Casdin, Its: Managing Member 2021-07-21 Casdin Partners GP LLC, By: /s/ Eli Casdin, Its: Managing Member 2021-07-21 Casdin Private Growth Equity Fund, L.P., By: Casdin Private Growth Equity Fund GP, LLC, By: /s/ Eli Casdin, Its: Managing Member 2021-07-21 Casdin Private Growth Equity Fund GP, LLC, By: /s/ Eli Casdin, Its: Managing Member 2021-07-21